Member Info for PL75

I agree, Sir Al needs to learn a few under promise over deliver phrases. We need to come up with a list of vague, but promising timeframes he can use. ‘As soon as possible during the summer’ was a winner, I don’t know why he didn’t stick with that one rather than anything involving ‘weeks’. A ‘few’ or a ‘couple’ just isn’t good for people’s mental health.

Thought we’d agreed they weren’t going to bother as it’s too late?

Bet you a fiver he’s just announcing he’s got £5bn quid to spend. He might talk about emerging tests, but I’d be amazed, delighted, shocked, surprised, flabbergasted, *insert other reaction here* if Awacta get any mention.

Don't spend it all at once Matt, you'll only regret it when Awacta pops up with the game changer...

After hours RNS anyone?! Imagine...

Perhaps he's going to take a sh.t at the despatch box to demonstrate the new Integumen / Awacta test?

Oh, ok, we're now suddenly including B2B in DTC then...

My point was that DTC won't be substantial, certainly in the short term. I stick by that. At the moment the only interest via Medusa would have been us lot. Initial orders that will hoover up all our supply will come from Govt. Remind me if I'm wrong.

I think you misunderstand the agreement with Medusa. They only have exclusive rights for DTC, not B2B.

@BBN, no idea why that was addressed at me. I’ve not said we’re involved in the trial. I said it could help speed up validation as the govt are aware of Awacta. Picture the scene, we’ve got our test ready (should be very soon), we then need to validate it, we’d need some actual humans and some of them need to be infected. Working with the govt as this stage is vital.

Anyone else getting deja vu? The good news is that the govt have a trial running and they’re fully aware of Awacta. This could speed validation up considerably.

Then we’ll agree to disagree BBN. I don’t place much importance on Medusa. It’s would have been a great PR stunt, but as the Kamani name is currently mud it might be best to down play it anyway.

I think the conversation will be with Matt Handjob who will ask what our capacity will be and he’ll place an order for the lot. He’s got £5bn in his purse. Ideally there’ll be a similar conversation with Cytiva and Trump.

DTC might come later if venues insist on them prior to entry to mass gathering events, but even then you might imagine they’d be offered in a ticket price and it’d be the business buying rather than DTC.

I’d imagine that the interest isn’t that great currently as there’s been limited PR and releasing those expressions of interest would be shooting themselves in the foot. Currently it’s putting the cart before the horse. Once we’ve got a product moving to production and the UK and hopefully US govts start waving them about, I’m sure PR and orders will take care of themselves. Any initial production capacity won’t touch the sides.

Yeah Gazala, it’s a good entry point over there, as you’ve said this is the real game changer, but you’d expect them to pick up sales in their target markets.

Gazala, still got a small position over there, it’s a stinker, but hey ho, it’ll either happen or not. I wasn’t spiked, or at least thought I wasn’t, it’s looking more like it! They’ve got a good Cytiva product, they just need to sell a few.

I’m a fan of this visualisation... https://ourworldindata.org/epi-curve-covid-19

Shows the number of tests per case so a good indicator of the volume of tests required at a glance. Basically if you see anything red or orange they’re struggling

An excellent point FF, there was complete radio silence from Sona, absolutely nowt until the big one arrived. We’ve been provided with additional updates, cheeky tweets, videos, news on another route to market... communication from Awacta is actually very good. Try the GDR board for laughs if you want to read about a lack of comms, over there they’re jealous of Awacta’s PR.

I’m not a premium member so you’ll have to post here or in general chat if you’d like to whisper sweet nothings in my ear xx

Morning TV, nope we’ve no idea, but we might find it’s as convoluted but crucially minus the uncomfortable swab. It might come with solvent and a pipette as well, but if the instructions are clear and that means we can get higher S&S levels, it’s got to be better than a lower performance test that people drool straight on to.

Here’s a lovely picture, how many people do you think do this properly?

https://health.ucdavis.edu/coronavirus/images/coronavirus-testing.PNG

Oh no. Chengdo is right. I’ve become the very thing that I feared the most. I need to make amends immediately by upping my subtle deramping to reinstate my rightful place in a green box and on a list a few places behind Gordon Chengkko. Here goes...

Anyone else worried that every rise will be sold in to by people that bought in higher and are trying to get out before all the competition arrives? I’m concerned that we’ll be stuck at 120p for a very long time.

That ought to do it.

No need to mention that gazala, it’s a medical condition, ok.